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ABSTRACT
To reveal the full potential of human pluripotent
stem cells, new methods for rapid, site-specific
genomic engineering are needed. Here, we
describe a system for precise genetic modification
of human embryonic stem cells (ESCs) and induced
pluripotent stem cells (iPSCs). We identified a novel
human locus, H11, located in a safe, intergenic, tran-
scriptionally active region of chromosome 22, as the
recipient site, to provide robust, ubiquitous expres-
sion of inserted genes. Recipient cell lines were es-
tablished by site-specific placement of a ‘landing
pad’ cassette carrying attP sites for phiC31 and
Bxb1 integrases at the H11 locus by spontaneous
or TALEN-assisted homologous recombination.
Dual integrase cassette exchange (DICE) mediated
by phiC31 and Bxb1 integrases was used to insert
genes of interest flanked by phiC31 and Bxb1 attB
sites at the H11 locus, replacing the landing pad.
This system provided complete control over
content, direction and copy number of inserted
genes, with a specificity of 100%. A series of
genes, including mCherry and various combinations
of the neural transcription factors LMX1a, FOXA2
and OTX2, were inserted in recipient cell lines
derived from H9 ESC, as well as iPSC lines derived
from a Parkinson’s disease patient and a normal
sibling control. The DICE system offers rapid, effi-
cient and precise gene insertion in ESC and iPSC
and is particularly well suited for repeated modifica-
tions of the same locus.
INTRODUCTION
Pluripotent stem cells, including embryonic stem cells
(ESCs) and induced pluripotent stem cells (iPSCs), offer
tremendous potential—for understanding human develop-
ment and disease mechanisms and for use in drug
screening and cell therapy strategies. New methods are
needed to insert genes in these cells in a controlled
manner, as current technologies have serious limitations.
For example, gene insertion mediated by retroviruses,
lentiviruses, transposons and non-homologous end-
joining (NHEJ) results in random integration. The conse-
quent lack of control over transgene insertion site, copy
number and orientation compromises the precision of
experiments. Moreover, these methods often have limits
on the size of the DNA that can be inserted.
Gene insertion using the canonical phiC31 phage
integrase can be performed with high stringency (1–4)
and has been used to insert BACS of over 100 kb in size
(5). Integration mediated by phiC31 and certain related
phage integrases such as Bxb1 provides unidirectional re-
combination that is tightly restricted to each enzymes’
own small attB and attP recognition sites (3,6,7).
However, these target att sites are not naturally present
in mammalian genomes. To enable high recombination
frequency, the att sites must be introduced into the
genome. Homologous recombination (HR) provides a
route to precise gene addition (8), but spontaneous
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recombination is inefﬁcient, size-sensitive and requires sig-
niﬁcant homology arms, thus making it laborious to
perform. Recombination frequency could potentially be
reduced even further if the cells under study exhibit
disease pathology. The frequency of HR can be stimulated
by provision of a double-strand break at the target site;
the break can be produced by zinc ﬁnger nucleases (9),
TALENs (10) and CRISPR/Cas9 technologies (11).
However, creating double-strand breaks may have
undesirable side effects, including cellular toxicity, off-
target recombination and sequence alterations near the
target site.
Here, we combine the attractive features of site-speciﬁc
integrases and HR to create a new method for precise gene
addition in human pluripotent stem cells. This method,
called dual integrase cassette exchange (DICE), offers
complete control over the content, orientation and copy
number of gene insertion and is expected to have no size
limits. In the DICE method, HR is utilized for placement
of a small ‘landing pad’ equipped with attP sites for two
phage integrases that recognize only their own small rec-
ognition sites (Figure 1A). The landing pad was directed
to a novel locus that was chosen by bioinformatics
analysis and expected to provide robust transcription in
all cell types. The murine Hipp11 locus was ﬁrst described
by Hippenmeyer et al. (12) and further validated in mice
for integrase-mediated transgenesis (13) and widespread
expression (14). The orthologous human H11 locus is
described here for the ﬁrst time. We pursued both spon-
taneous and TALEN-assisted HR for placement of the
landing pad into H11, uncovering a requirement for
assisted recombination when modifying a disease iPSC
line with signiﬁcant pathology. Once recipient cell lines
were created that bore the landing pad in the favorable
H11 locus, a cassette-exchange strategy was applied to
insert genes of interest. The cassette exchange was
mediated by two different site-speciﬁc integrases, phiC31
and Bxb1, each directing highly accurate recognition and
synapsis of its own sites, with no cross-recognition of the
att sites of the other integrase. In this way, only the desired
sequence was inserted, devoid of unneeded ﬂanking
plasmid sequences that could be deleterious (13).
Furthermore, only a single copy was inserted, as is
typical for integrases, whether one or two integrases are
used. By using two integrases, the reaction was invariably
precise, producing only the desired orientation. This
feature eliminated unwanted integration of the plasmid
backbone and ensured that the transgene was always
inserted in the same orientation with respect to the
genome. This outcome permits various transgenes to be
compared faithfully in the identical genomic context,
eliminating potential variation in expression due to
orientation.
In this study, insertion of GFP and mCherry marker
genes conﬁrmed robust gene expression at H11.
Moreover, by applying the DICE strategy, we were able
rapidly to produce a large series of ESC and iPSC lines
carrying different combinations of neuronal transcription
factor genes. These lines will be useful for analyzing dif-
ferentiation of stem cells into dopaminergic neurons, as a
potential therapeutic approach for Parkinson’s disease
(PD) (15). This study demonstrates that DICE is a
simple strategy for precise gene addition that is effective
in human ESC and iPSC and is particularly useful for
creating a series of cell lines starting from the same
parent line, with various genes inserted at the same
chosen, desirable location.
MATERIALS AND METHODS
Plasmid construction
PCR reactions for plasmid construction were performed
with either Phusion DNA polymerase (New England
Biolabs, Ipswich, MA, USA) or KAPA HiFi HotStart
ReadyMix (2) (KAPA Biosystems, Woburn, MA,
USA). All DNA fragments ampliﬁed by PCR were com-
pletely sequenced after cloning. Primers used to generate
the homology arms are listed in Supplementary Table S1.
For the landing pad plasmid p2attNG, the structure of the
Neo and GFP exchange cassette is provided in
Supplementary Figure S1A. The homology arms for HR
at the human H11 locus in the landing pad plasmid were 5
and 3 kb in length, while homology arms of 400 bp on each
side were used for TALEN-assisted recombination. For
the donor plasmid, the structure of plasmid p2attPC-
LFO is provided in Supplementary Figure S1B. The con-
structs with two of the three transcription factors and
the control plasmid lacking transcription factors were
generated based on the p2attPC-LFO plasmid.
Transcription factor cDNA sequences were purchased
from DNASU, the DNA repository at Arizona State
University. Plasmid sequences will be made available
upon request.
For TALEN targeting plasmid construction, TALEN
repeat variable di-residues (RVDs) were designed by
the TAL Effector Nucleotide Targeter 2.0 (10,16) (spacer
15–24, RVDs=15–20). TALEN-encoding plasmids were
assembled using the Golden Gate TALEN and TAL
Effector Kit 1.0 and its protocol for assembly of the
TALEN-encoding plasmid (Addgene; www.addgene.
org). The mammalian expression vector with modiﬁed
FokI was a kind gift from Dr Matthew Porteus,
Stanford University. The efﬁciency of induction of
double-strand breaks by transcription activator-like
effector (TALE) pairs was determined by using the
SURVEYOR Mutation Detection Kit (Transgenomic
Inc., Omaha, NE, USA).
Cell culture and differentiation
Human pluripotent stem cells, including H9 ESC, PI-1761
and PI-1754 iPSC, and subclones derived from these cells,
were cultured on irradiation-inactivated mouse embryo
ﬁbroblasts (MEFs) in human stem cell culture medium
consisting of Dulbecco’s modiﬁed eagle medium/F12
(DMEM/F12), 20% knockout serum replacement,
0.1mM non-essential amino acids (NEAA), 2mM
glutamax, 0.1mM b-mercaptoethanol (2-ME) (all from
Invitrogen, Carlsbad, CA, USA) and 10 ng/ml bFGF
(R&D Systems, Minneapolis, MN, USA). Culture
medium was changed daily. H9 and PI-1761 cells were
passaged every 5–7 days using 1mg/ml collagenase IV
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(Invitrogen), while PI-1754 PD patient iPSCs were
manually passaged every 7–10 days.
For embryoid body (EB)-mediated differentiation, cells
were incubated with 1mg/ml dispase (Invitrogen)
for 15min, washed, and then colonies were har-
vested and transferred from 6-well plates to ultra low at-
tachment surface 6-well plates (Corning, Tewksbury, MA,
USA) in differentiation medium containing DMEM/F12,
15% fetal bovine serum (Invitrogen), 0.1mM NEAA,
2mM glutamax and 0.1mM 2-ME. Medium was
changed every 2–3 days. After 8 days in suspension
culture, EBs were collected, reseeded onto 24-well plates
pre-coated with 0.1% gelatin (Sigma Aldrich, St. Louis,
MO, USA) and cultured for another 8 days in the same
medium.
Nucleofection and stable line generation
Nucleofection was performed using the P3 Primary Cell
4D-Nucleofector X Kit L (Lonza, Walkersville, MD,
USA) according to the manufacturer’s instructions.
Brieﬂy, cells were dissociated with Accutase (Millipore,
Billerica, MA, USA) into single cells, depleted of MEF
feeders and counted. Then, 0.8–1.6 106 cells were
nucleofected in one cuvette and quickly reseeded onto
multi-antibiotic resistant DR4 MEF cells (Applied
StemCell, Menlo Park, CA, USA) freshly prepared 1
day earlier. The Rho kinase inhibitor Y27632 (Tocris
Bioscience, Bristol, UK) was used 24 h before and after
nucleofection to promote cell survival.
For generation of recipient ESC and iPSC lines, 5 mg
landing pad plasmid was used for spontaneous HR, and
Figure 1. DICE strategy and H11 location. (A) Schematic diagram describing a two-step process for robust and easily repeatable placement of any
genes into human pluripotent stem cells. First, the attP-ﬂanked Neo-GFP landing pad is introduced into the H11 locus by HR to generate a recipient
cell genome. The position of the probe (G probe) used to characterize the recipient cell lines by Southern blotting is indicated. Then, the donor gene
cassette is recombined into this location by DICE. In this case, the donor cassette carries genes for neural transcription factors (F), as well as
puromycin resistance and mCherry genes for selection and screening. (B) Location of the H11 locus in the human genome. H11 resides in an
intergenic region on chromosome 22q12.2, ﬂanked by the DRG1 and EIF4ENIF1 genes. The distances from H11 to the terminal exons of the two
ﬂanking genes are indicated.
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8 mg landing pad plasmid and 1 mg TALEN-encoding
plasmids were used for TALEN-mediated recombination.
For DICE, 4 mg was used for each of phiC31 integrase
[pCS-kI; (17)], Bxb1 integrase [pCMV-Bx; (6)] and attB
donor plasmids. Cells were selected with either 50 mg/ml
G418 (Invitrogen) for HR or 500 ng/ml puromycin
(Invitrogen) for DICE, starting 2–4 days after
nucleofection and exposing cells to puromycin for only
2–3 days. Surviving clones that were mCherry-positive
and GFP-negative were picked 2 weeks after drug selec-
tion and expanded for further experiments.
Genomic PCR
Genomic DNA was extracted using ZR Genomic DNA II
kit (Zymo Research Corp., Irvine, CA, USA) or
QuickExtractTM DNA Extraction Solution (Epicentre
Biotechnologies, Madison, WI, USA) according to the
manufacturer’s instructions. Genomic PCR was per-
formed with GoTaq Green Master Mix (Promega
Biosystems, Sunnyvale, CA, USA). Primers used are
listed in Supplementary Table S1.
Southern blotting
Genomic DNA was puriﬁed from cells by standard
phenol/chloroform extraction and digested with ScaI-HF
(New England Biolabs) for 6–8 h, supplemented with
1mM spermidine (Sigma), 100 mg/ml bovine serum
albumin (BSA; Sigma) and 50 mg/ml RNAse A
(Millipore). About 10 mg digested DNA from each clone
was separated on 0.8% agarose gels and transferred
to hybond-N+ nylon membrane (GE Healthcare,
Piscataway, NJ, USA). The GFP probe targeted to the
GFP transgene was generated by PCR, and the primer
sequences are listed in Supplementary Table S1. The
labeling of probe and hybridization with the membranes
were performed according to the manufacturer’s instruc-
tions (Amersham Rediprime II labeling system, GE
Healthcare).
Immunocytochemistry
Cells were ﬁxed in 4% (wt./vol.) paraformaldehyde
(Electron Microscopy Sciences, Hatﬁeld, PA, USA) for
20min, rinsed with phosphate buffered saline (PBS),
permeabilized and blocked by 3% normal donkey serum
(Jackson ImmunoResearch Laboratories, Bar Harbor,
ME, USA) in PBST (PBS+0.2% TritonX-100; Sigma)
for 60min at room temperature. Cells were incubated
with primary antibodies in PBST at 4C overnight and
then washed with PBS three times. Then cells were
incubated with secondary antibodies diluted in PBS
containing 0.1% BSA (Jackson ImmunoResearch
Laboratories) for 1 h at room temperature. Finally, the
cells were counter-stained for nuclei with 1 mg/ml DAPI
(Roche, Nutley, NJ, USA).
Primary antibodies used in this study include rabbit anti-
OCT3/4, rabbit anti-SOX2, rabbit anti-NANOG, mouse
anti-SSEA4 (all from Cell Signaling Technology, Beverly,
MA, USA), mouse anti-TRA-1-60 (Millipore), mouse
anti-TRA-1-81 (Millipore), mouse anti-AFP (Cell
Signaling Technology), mouse anti-alpha-SMA (Abcam,
Burlingame, CA, USA), mouse anti-bIII-Tubulin
(Covance, Princeton, NJ, USA), goat anti-FOXA2 (R&D
Systems), rabbit anti-OTX2 (Millipore) and rabbit anti-
LMX1a (Millipore). Secondary antibodies were Alexa
Fluor 488/594-conjugated donkey anti-mouse/rabbit/goat
(Jackson ImmunoResearch Laboratories).
Karyotyping
G-banded karyotyping was performed by WiCell
Cytogenetic Services, Madison, WI, USA.
RESULTS
H11 locus and DICE strategy
We previously described a transcriptionally and
recombinationally active, ubiquitously expressed murine
locus called Hipp11 (12–14). Hipp11 is located in an
intergenic region on chromosome 11, ﬂanked by the two
genes Drg1 and Eif4enif1 (12). The criteria for identiﬁca-
tion of the Hipp11 locus included absence of disruption of
regulatory elements or genes, as judged by sequence an-
notation, an intergenic region in a gene dense area, a
location at the convergence between two genes transcribed
in opposite directions and apparently ubiquitous tran-
scriptional activity, as reﬂected by broad spatial and
temporal expressed sequence tag expression patterns,
indicating ubiquitous transcriptional activity. This latter
feature is especially important in stem cells, where during
differentiation, chromatin remodeling typically leads to
silencing of some loci and potential activation of others.
Within the region, a precise locus was chosen that was
devoid of repetitive elements and conserved sequences
and to which primers for ampliﬁcation of homology
arms could easily be designed. In vivo experiments
veriﬁed that integration of targeting cassettes at Hipp11
did not interfere with viability or fertility of mice and that
biallelic expression of targeting cassettes was possible.
Studies in mice conﬁrmed that genes inserted at Hipp11
displayed robust, ubiquitous expression that appeared to
be superior to the expression levels of other commonly
used ubiquitously active loci, including ROSA26 (12–14).
To identify the orthologous locus in the human genome,
we ﬁrst located DRG1 and EIF4ENIF1 in human chromo-
somes and located the human equivalent locus, called
H11, by its distance from these two genes. Human
DRG1 and EIF4ENIF1 are located on chromosome
22q12.2, the distance between the two genes is very
similar between mouse and human, and the intron/
exon organization of DRG1 and EIF4ENIF1 is highly
conserved between the two species. We screened the
region 700 bp 30 to the 30 UTR of human EIF4ENIF1
and chose a locus where primers could readily be designed
for ampliﬁcation of homology arms, 4500 bp downstream
of DRG1 and 683 bp downstream of EIF4ENIF1
(Figure 1B). The level of DNA sequence identity
between the mouse Hipp11 and human H11 regions was
45%, similar to the average sequence identity between
mouse and human of 40%, reﬂecting the absence of highly
conserved sequences in the region and consistent with a
safe region for insertion of transgenes. Because of the
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parallels with the mouse location, we speculated that the
H11 locus would allow strong expression of inserted genes
without disrupting endogenous gene function.
We then combined the human H11 locus, spontaneous
or TALEN-assisted HR and phiC31 and Bxb1 integrases
to create an efﬁcient site-speciﬁc integration system
for ESC and iPSC. The overall strategy is shown in
Figure 1A. The landing pad construct carried neomycin
resistance and GFP genes for selection and screening,
ﬂanked by attP sites for phiC31 and Bxb1 integrases.
This cassette was placed into the human H11 locus by
using either spontaneous or TALEN-assisted HR to
generate recipient ESC and iPSC lines. Neomycin selec-
tion was used to identify clones that had integrated the
landing pad, while GFP expression provided an indication
of the level of gene expression from the locus.
In the second step, we performed DICE to introduce the
genes of interest into the H11 locus in the recipient cell
lines. PhiC31 integrase and Bxb1 integrase were combined
to generate a high degree of speciﬁcity and directionality
for the cassette exchange reaction. The donor cassette
carried puromycin resistance and mCherry genes for selec-
tion and screening, in addition to the gene of interest, for
example, neural transcription factor genes. These donor
genes were ﬂanked by attB sites for phiC31 and Bxb1,
to target site-speciﬁc recombination. PhiC31 and Bxb1
integrases recognize and recombine their attP and attB
sites with a high degree of speciﬁcity using concerted cut
and paste recombination events (18), resulting in all genes
internal to the attB sites being inserted into the genome in
a deﬁned orientation and copy number. Therefore, in this
system, DICE will ensue when the donor plasmid along
with phiC31 and Bxb1 integrase-expressing plasmids are
co-transfected into recipient cell lines. Through this two-
step strategy, which combines genome editing methods
mediated by HR and by site-speciﬁc integrases, we estab-
lished a highly speciﬁc, precise and convenient system for
editing ESC and iPSC genomes.
Homologous recombination at the H11 locus and
generation of recipient cell lines
We ﬁrst utilized spontaneous HR to insert the landing pad
cassette into the H11 locus in H9 ESC. The targeting
vector contained an expression cassette carrying the
neomycin resistance and GFP genes, ﬂanked by the attP
sites for phiC31 and Bxb1 integrases and two homology
arms, of 5 and 3 kb (Supplementary Figure S1A). The
targeting vector was linearized by digestion with SwaI
and AscI and introduced into H9 cells by an optimized
nucleofection protocol. G418 selection was started 2 days
later and continued for 14 days, after which GFP-positive
clones were picked and screened by genomic PCR and
Southern blotting. Out of 98 clones analyzed, 6 underwent
the desired recombination event (Figure 2A), indicating a
targeting frequency of 6.1% in H9 ESC (Table 1).
We then asked whether iPSC could be genetically
modiﬁed at the H11 locus by the same method. For these
experiments, we used PI-1754 iPSC from a PD patient (19)
and PI-1761 iPSC from a normal sibling control. The PI-
1754 iPSC line was generated from a PD patient with a
triplication of the alpha-synuclein (SNCA) gene, and it
exhibits PD-related pathological phenotypes in culture
after differentiation into dopaminergic neurons (19). The
landing pad vector for the iPSC was the same as that used
for H9, except that the homology arm sequences were
slightly different, reﬂecting minor DNA polymorphisms
observed between these three human genomes (data not
shown). Similar procedures were performed to carry out
HR in PI-1754 and PI-1761 iPSC. For the normal sibling
control PI-1761, two correctly targeted clones were identiﬁed
out of 35 picked (5.7%; Table 1). However, we failed to get
any correctly targeted clones among 23 clones picked for the
PD patient-derived PI-1754 iPSC. This result may have been
due to the disease-related phenotype of the PI-1754 iPSC,
which is reﬂected in poor growth and propensity for differ-
entiation upon passaging and after nucleofection. This
phenotype is in contrast to the robust growth of the wild-
type PI-1761 iPSC and H9 ESC lines, even after passaging
and nucleofection.
In an attempt to stimulate the frequency of HR, which
appeared critical for PI-1754 iPSC, we applied the recently
described TALEN genome-editing method to generate
double-strand breaks in a site-speciﬁc manner. Such
breaks can be used to target the spontaneous HR system
at an elevated frequency. TALEs are a newly described
class of speciﬁc DNA-binding proteins from Xanthomonas
plant pathogens (20). These proteins contain DNA-binding
domains of TALE repeats composed of 33–35 amino acids.
The TALE repeats have almost identical sequences, except
for the ‘RVD’, which speciﬁcally recognize one target base.
Repeats with the appropriate speciﬁcity are linked to a
nuclease domain to generate a TALE-nuclease (TALEN).
TALENs are straightforward to design and construct (10)
Figure 2. Generation of recipient ESC and iPSC lines. (A) Genomic
PCR was used to screen for clones that underwent correctly targeted
spontaneous HR in H9 ESC, producing integration of the landing pad
cassette at the H11 locus. A 3.6-kb band indicated correct targeting. (B)
The TALEN pair used in this study to target the human H11 locus.
Color code for the amino acid positions 12 and 13 in a TALE repeat
and the corresponding nucleotide in DNA: red NI for A, green HD for
C, blue NG for T and purple NN for G. The double-strand break was
generated 60 bp from the H11 locus. (C) Genomic PCR was used to
screen for clones that underwent correctly targeted placement of the
landing pad by TALEN-assisted HR in PI-1761 iPSC. Representative
clones are shown, with the expected 1.1 kb band indicating correct
placement.
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and induce double-strand breaks in speciﬁc DNA
sequences. The breaks will be repaired by the cell using
either homology-directed repair or the error-prone
process of NHEJ. TALENs have been shown to be effective
for genome editing in human pluripotent stem cells (21),
although as with other methods of artiﬁcially stimulating
HR through provision of targeted double-strand breaks,
off-target effects and unwanted mutagenesis can occur.
We identiﬁed two potential TALEN target sites
(Spacer=15–24 bp, RVDs=15–20 bp) for the H11
locus using the TAL Effector Nucleotide Targeter 2.0
(10,16), with one located exactly at the H11 locus, while
the other was 60 bp from the locus. TALEN pairs were
assembled according to the Golden Gate methodology
(10) (Figure 2B). We then determined the efﬁciency of
these two pairs of TALENs to make double-strand
breaks in the K562 cell line by a mutation detection kit.
This assay is based on the generation of PCR products
that are subsequently hybridized to generate mismatches
in heteroduplexed DNA, and cleavage of the mismatches
by a nuclease. According to this assay, the second TALEN
pair (Figure 2B) showed a higher efﬁciency of double-
strand breaks of 25% and was therefore chosen for
genomic manipulation in ESC and iPSC (data not
shown), even though it was farther from the locus.
For TALEN-assisted HR at the H11 locus in ESC and
iPSC, we used the same landing pad plasmid that was used
for spontaneous recombination. However, shorter homology
arms, of only 400bp of homologous sequences ﬂankingH11,
were employed. We introduced the two TALEN expression
vectors and the landing pad plasmid into H9 ESC and
PI-1761 and PI-1754 iPSC by nucleofection. After similar
neomycin drug selection and GFP screening procedures,
genomic PCR analysis (Figure 2C), revealed that 7 of 12,
15 of 33 and 13 of 24 clones underwent the correct the re-
combination event in H9 ESC, and 1761 and 1754 iPSC,
respectively, indicating a targeting efﬁciency of 40–50%,
even for the PD patient 1754 iPSC (Table 1). These results
represented a dramatic increase in recombination frequency
of 8-fold at the H11 locus in human ESC and iPSC
mediated by TALEN-assisted HR. Therefore, the TALEN
system was efﬁcient for genomic editing, even in disease
iPSC where spontaneous HR was ineffective.
Characterization of ESC and iPSC recipient stem
cell lines
To identify ESC and iPSC recipient lines that have attP
sites anchored at the H11 locus for use in further
experiments, we ﬁrst screened some of the correctly
targeted clones for integration copy number by Southern
blotting, using a probe directed to the GFP gene in the
landing pad cassette (Figure 1A). To determine whether
one or both of the H11 alleles had been recombined, we
performed genomic PCR using primers targeting regions
around H11 in the human genome (Supplementary
Figure S2B). The results showed that all clones tested
that had been generated by spontaneous recombination
had integrated a single copy of the landing pad, while
some of the tested clones that resulted from TALEN-
assisted recombination had integrated multiple copies
(Figure 3A; Supplementary Figure S2A). Some of the
single-copy clones were sequenced to examine whether
there were any mutations in the region, including the
landing pad cassette and the homology arms. Mutations
were detected in regions around the double-strand break
in some of the clones derived from TALEN-assisted re-
combination. These results suggest that residual TALENs
may have created additional double-strand breaks after
the desired recombination event occurred, and NHEJ
may have mediated DNA repair, generating these muta-
tions. Additional breaks could occur, because the
TALENs were targeted to a region 60 bp from the H11
locus, so the intact target continued to exist, even after the
correct recombination event occurred. From the clones
that were single-copy and mutation free, we randomly
selected one clone for each cell line, namely a22 for H9,
f5 for PI-1761 and t17 for PI-1754, for further character-
ization as candidates to become validated recipient cell
lines. Because we did not characterize all the clones, we
do not know the frequency of mutation-free clones, but it
was not difﬁcult to ﬁnd such clones.
We tested whether these recipient lines, named
H9-2attNG (a22), 1761-2attNG (f5) and 1754-2attNG
(t17), remained pluripotent after genetic manipulation by
immunostaining for pluripotency marker genes and by
EB-mediated in vitro differentiation. All three cell lines
exhibited the typical morphology of pluripotent ESC
and iPSC (Figure 4A) and expressed GFP and a panel
of pluripotency marker genes, including OCT3/4, SOX2,
NANOG, SSEA4 and TRA-1-60 (Figure 4B). After
16 days of in vitro differentiation, all lines generated
cells positive for markers of the three germ layers,
including alpha-fetoprotein (endoderm), alpha-smooth
muscle actin (mesoderm) and beta III-tubulin (ectoderm)
(Figure 4C). Meanwhile, robust GFP expression was
maintained in the three cell lines after extensive passaging
Table 1. Summary of HR experiments for generation of recipient ESC and iPSC lines
Cell line Targeting method Landing pad Number of clones
analyzed
Number of correctly
targeted clones
Targeting
efﬁciency (%)
H9 ESC Spontaneous HR 5kb arm-Neo-GFP-3 kb arm 98 6 6.1
1761 iPSC Spontaneous HR 5kb arm-Neo-GFP-3 kb arm 35 2 5.7
1754 iPSC Spontaneous HR 5kb arm-Neo-GFP-3 kb arm 23 0 0
H9 ESC TALEN-assisted HR 0.4 kb arm-Neo-GFP-0.4 kb arm 12 7 58.3
1761 iPSC TALEN-assisted HR 0.4 kb arm-Neo-GFP-0.4 kb arm 33 15 45.5
1754 iPSC TALEN-assisted HR 0.4 kb arm-Neo-GFP-0.4 kb arm 24 13 54.2
The last column shows the percentage of correctly targeted clones for each condition.
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(>30 passages) and after EB-mediated differentiation
(Figure 4C), suggesting robust expression from the H11
locus. Finally, G-banded karyotype analysis showed that
all three recipient cell lines retained a normal karyotype
(Figure 3B).
In summary, recipient cell lines H9-2attNG ESC and
1761-2attNG and 1754-2attNG iPSC were successfully
established, bearing phiC31 and Bxb1 integrase attP
sites placed at the transcriptionally active H11 locus.
Because these attP sites are recognized and actionable
by the phiC31 and Bxb1 integrases, the recipient cell
lines can be used to insert and express any genes of
interest that are ﬂanked by phiC31 and Bxb1 attB sites.
Dual integrase cassette exchange in H9-2attNG
A key feature of our strategy is that transient expression of
phiC31 and Bxb1 integrases in recipient cell lines will
catalyze site-speciﬁc, irreversible recombination between
cognate attP and attB sites, resulting in precise replace-
ment of the landing pad cassette by any donor cassette
ﬂanked by phiC31 and Bxb1 attB sites. We named this
process DICE (Figure 1A). To determine the efﬁciency
of DICE in a recipient cell line, we constructed a control
donor vector in which phiC31 and Bxb1 attB sites ﬂanked
genes for the puromycin resistance selection marker and
the mCherry ﬂuorescent marker protein, driven by
the PGK promoter (Supplementary Figure S1B). We
introduced this vector together with phiC31 and Bxb1
integrase expression vectors into the H9-2attNG recipient
cell line by nucleofection, and started puromycin drug se-
lection 3–5 days later, for 2–3 days. Within several days,
the change in marker gene expression from GFP to
mCherry was visible (Figure 5A). We did not observe
any puromycin-resistant clones that were mCherry-
negative, and all the puromycin-resistant clones showed
complete conversion of cells from green to red. This
result was expected, as puromycin and mCherry are
expressed by the same promoter, linked by P2A. After
2 weeks, 12 puro-resistant clones that were mCherry-
positive and GFP-negative were picked at random. We
tested whether DICE had occurred in these clones by per-
forming genomic PCR using primers designed to detect
the landing pad or donor cassettes. The results showed
that all 12 of the clones (H9-PC) carried the puromycin–
mCherry donor cassette at the H11 locus, while the
landing pad cassette was no longer present. This result is
consistent with DICE having successfully occurred in
100% of the picked clones (Figure 5B; Supplementary
Figure S3).
Overexpression of neural transcription factors in
recipient stem cell lines
We further asked whether the DICE genomic editing
system could be employed as a rapid method to create
cell lines that may be useful to optimize differentiation
protocols into speciﬁc lineages by overexpressing
relevant transcription factors. The transcription factors
Lmx1a, FoxA2 and Otx2 were previously shown to be
Figure 3. Southern blotting and G-banding analysis of recipient cell lines. (A) Southern blot analysis of selected clones. Marker lanes refer to size
markers, with 9.1 kb for spontaneous HR and 12.0 kb for TALEN-assisted HR (arrows). Clones given the ‘a’ and ‘b’ preﬁxes were from H9 ESC
targeted by spontaneous HR, while ‘f’ and ‘g’ preﬁxes indicate clones derived from PI-1761 iPSC, also targeted by spontaneous HR. The t clones
were from PI-1754 iPSC targeted by TALEN-assisted HR. (B) G-banding analysis of recipient cell lines, including H9 recipient cell line H9-2attNG
(a22), PI-1761 recipient cell line 1761-2attNG (f5) and PI-1754 recipient cell line 1754-2attNG (t17).
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Figure 4. Pluripotency of recipient ESC and iPSC lines. (A) Typical ESC and iPSC morphology of the recipient cell lines H9-2attNG (left), 1761-
2attNG (middle) and 1754-2attNG (right). (B) Immunostaining of pluripotent markers OCT3/4, NANOG, SSEA4 and TRA-1-60, for H9-2attNG
(upper), 1761-2attNG (middle) and 1754-2attNG (lower). (C) Typical morphology of suspended EBs at Day 8 (left) and immunostaining of marker
genes for the three germ layers: AFP (endoderm), alpha-SMA (mesoderm) and Tuj1 (ectoderm) from H9-2attNG (upper), 1761-2attNG (middle) and
1754-2attNG (lower). Scale bar, 200mm.
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critical for dopaminergic neuron development in mouse
(22). Forced expression of these factors individually or
in combinations in ESC improved neuronal differentiation
(23–25). We hypothesized that overexpression of these
factors speciﬁcally at the neural stem cell stage during
directed differentiation from ESC or iPSC might be effect-
ive in increasing differentiation efﬁciency into dopamin-
ergic neurons. To this end, we designed a series of four
constructs, based on the control p2attPC donor vector,
that carried the human LMX1a (L), FOXA2 (F) and
OTX2 (O) coding sequences in all pairwise combinations
and with all three together. GFP (G) was also included
as a reporter, and the entire cassette was driven by the
NESTIN enhancer and minimal thymidine kinase
promoter. With this design, we expected that, at the
stage of neuronal differentiation when the neural progeni-
tor marker NESTIN is expressed, the inserted genes would
be expressed as well.
We used ribosomal skipping 2A sequences, including 2A
peptide regions from equine rhinitis A virus (‘E2A’),
porcine teschovirus-1 (‘P2A’) and insect Thosea asigna
virus (‘T2A’), to generate multicistronic vectors for
efﬁcient translation of the inserted genes (26,27)
(Supplementary Figure S1B). 2A peptides have been
reported to mediate stoichiometric production of separate
proteins from dicistronic or multicistronic genes in multiple
cell types (26). The sizes of the transgene cassettes present
between the two attB sites ranged from 5 to 7kb. We
introduced phiC31 and Bxb1 integrase expression
plasmids and each of the four different constructs into
H9-2attNG and carried out similar nucleofection, selection
and analysis procedures to those described above. Genomic
PCR analysis indicated that all clones (named H9-LFO,
H9-LF, H9-LO and H9-OF) tested had the desired donor
cassette present at the H11 locus, whereas the original NG
landing pad was no longer present, again indicating that
DICE is 100% speciﬁc (Figure 5B; Table 2).
To determine whether DICE would also be effective in
iPSC, we introduced the control p2attPC plasmid and
each of the four transcription factor constructs into the
1761-2attNG and 1754-2attNG recipient iPSC lines.
After co-transfection of phiC31 and Bxb1 integrase
expression plasmids and the donor construct and
puromycine selection, GFP-negative and mCherry-
positive clones were picked randomly. Genomic PCR
was used to detect which clones had undergone cassette
exchange. Although fewer puromycin-resistant colonies
were obtained from patient 1754 iPSC than from the
normal sibling control 1761 iPSC, all the randomly
chosen clones were positive for the desired cassette
exchange, as summarized in Table 2.
We then randomly chose two clones for further experi-
ments representing H9-LFO, carrying LMX1a, FOXA2,
OTX2 and GFP, and H9-PC, carrying only the puromycin
and mCherry genes and no transcription factors.
Both clones expressed a panel of typical pluripotentcy
markers, including OCT3/4, NANOG, SSEA4 and
TRA-1-60 (Supplementary Figure S4). Both clones also
produced cells representative of the three germ layers
after EB-mediated differentiation (Supplementary
Figure S5). To test further whether the pluripotency of
the lines was affected by the DICE procedure, H9 clones
carrying various transcription factors that had been added
by DICE were compared to H9 cells in which tran-
scription factors were not added. End-point reverse-
transcription PCR was carried out for ﬁve pluripotency
genes in the engineered and control H9 cells (Supple-
mentary Figure S6). Band intensity of pluripotency
genes was comparable in all the lines.
To determine whether the three transcription factors
were overexpressed in a neuronal cell-speciﬁc manner
in H9-LFO, we examined expression of the neuronal pro-
genitor marker NESTIN in EB-differentiated cells by
immunostaining and GFP by ﬂuorescence (Figure 6).
NESTIN was turned on in some cells during EB-
mediated differentiation, and these cells were also
labeled by GFP expression, consistent with NESTIN-
regulated expression of the transcription factor cassette.
In contrast, no GFP-positive cells were detected in EB-
differentiated cells from the control H9-PC (Figure 6B).
Figure 5. DICE reaction mediated by phiC31 and Bxb1 integrases. (A) The visible change in marker gene expression as mCherry replaces GFP 1 and
4 days after nucleofection. These cells may not be a single clone, as ESC tends to grow as clusters. Puromycin drug selection is used to obtain pure
recombinant cells. It takes 2 days for the cells to completely convert to mCherry expression. (B) An example of genomic PCR for screening of
correctly targeted clones after DICE, yielding a band of 1.2 kb. H9-LF (LMX1a-FOXA2) clones are shown. Scale bar, 200 mm.
PAGE 9 OF 13 Nucleic Acids Research, 2014, Vol. 42, No. 5 e34
Downloaded from https://academic.oup.com/nar/article-abstract/42/5/e34/1055802
by Institute of Science and Technology Austria user
on 30 January 2018
Immunostaining was then performed to examine the
expression of the three transcription factors at Day 16
of differentiation. The results showed that in
differentiated cells from the H9-PC control line, only a
few cells expressed FOXA2 and almost no cells expressed
LMX1a or OTX2, reﬂecting the expected low endogen-
ous expression pattern of these three transcription
factors in randomly differentiated cells. However, in cells
differentiated from the H9-LFO line, there were more cells
expressing LMX1a, FOXA2 or OTX2, and most of these
cells were also positive for GFP, suggesting that the ex-
pression of these introduced genes was activated by the
exogenous NESTIN enhancer (Figure 6C). Together
these results suggested that ESC and iPSC genomes
could be efﬁciently modiﬁed by the DICE method and
that genes of interest could be faithfully expressed at the
H11 locus, even after differentiation.
DISCUSSION
In this study, we developed a novel strategy to achieve
stringent site-speciﬁc integration in human ESC and
iPSC by combining TALEN-assisted HR at a newly
described locus for robust expression with DICE for
rapid and precise gene insertion. In our system, we ﬁrst
established recipient H9 ESC and PD and sibling control
iPSC lines that carried a landing pad with attP sites for
phiC31 and Bxb1 integrases. This step was accomplished
by either spontaneous or TALEN-assisted HR. The
correct recombination event occurred at a frequency of
6% by spontaneous recombination and 40–50% by
TALEN-assisted recombination, illustrating the beneﬁt
of TALENs to stimulate recombination. In the case
of the PD line, recombination was only successful
when TALENs were used. We then induced DICE by
introducing plasmids encoding phiC31 and Bxb1
integrases to mediate site-speciﬁc integration at the
landing pad. We co-introduced genes for mCherry and/
or the dopaminergic neuron-inducing transcription factors
LMX1a, OTX2 and FOXA2 in the context of a puro-
mycin resistance selection marker cassette into the recipi-
ent cell lines, achieving successful cassette exchange with a
speciﬁcity of 100% after screening and selection. We
demonstrated that transgenes inserted into the H11 locus
Figure 6. Characterization of overexpression of neural transcription factors in correctly targeted clones. (A) Typical ESC morphology of H9 clones
after DICE. H9-PC (control, left) and H9-LFO (LMX1a-FOXA2-OTX2, right) are shown. (B) The morphology of suspended EBs and the expres-
sion of mCherry and GFP at Day 8 from H9-PC (left) and H9-LFO (right). (C) Immunostaining of NESTIN, LMX1a, OTX2 and FOXA2 in the
H9-LFO line after 16 days of EB-mediated differentiation. Endogenous mCherry expression was weak and not detected by the ﬂuorescence micro-
scope used, so did not interfere with target protein staining. Scale bar, 200mm.
Table 2. Summary of DICE results in recipient ESC and iPSC lines
PC positive
clones/all clones
LFO positive
clones/all clones
LO positive
clones/all clones
LF positive
clones/all clones
FO positive
clones/all clones
H9-2attNG 12/12 12/12 12/12 9/9 7/7
1761-2attNG 17/17 11/11 7/7 3/3 5/5
1754-2attNG 5/5 4/4 2/2 3/3 2/2
PC, puromycin-mCherry; L, LMX1a; F, FOXA2; O, OTX2. Correct addition of marker genes alone or marker and transcription factor genes
occurred in 111/111 of the mCherry-positive, GFP-negative clones screened.
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were faithfully expressed in long-term culture of ESC and
iPSC and were expressed in cells of all three germ layers
after differentiation. Therefore, this genomic editing
system provides a methodology that will enable the use
of human ESC and iPSC in studies exploring gene
function, lineage tracking, disease modeling, drug discov-
ery and other goals.
Here, we have identiﬁed and targeted, for the ﬁrst time,
the H11 human homolog of the mouse Hipp11 locus (12).
H11 is in a transcriptionally active intergenic region of
human chromosome 22 that appears to be highly
suitable as a safe and effective location for placement of
transgenes in human cells. Our present study showed that
the targeting efﬁciency at H11 was high—approximately
5–6% by spontaneous recombination and 40–50% by
TALEN-assisted HR, both of which are higher than typ-
ically reported frequencies and suggestive of open chro-
matin. In addition, transgenes placed at the H11 locus
were actively and faithfully expressed without apparent
silencing for over 30 passages. We mapped 300 kb of
DNA sequence ﬂanking the H11 locus in the human
genome utilizing the UCSC database and found that
there were no cancer genes present in the region and
only one microRNA, 288 kb distant from H11. In these
respects, H11 compares favorably with the current widely
used loci for transgene insertion in human cells, ROSA26,
AAVS1 and HPRT1, all of which are in exons or introns
of endogenous genes and are differentially expressed in
different tissues (28). Therefore, H11 appears to be an
excellent locus for a wide variety of genome editing
purposes.
In addition, for the ﬁrst time, we employed two different
integrases simultaneously, phiC31 and Bxb1, to create a
more effective cassette exchange strategy. This strategy
conferred signiﬁcant advantages, as the use of dual
integrases provided high speciﬁcity and efﬁciency.
Previous cassette exchange studies utilizing serine
integrases have employed phiC31 integrase alone, in
Schizosaccharomyces pombe (29), Drosophila (30) and
mouse cells and embryos (1,2,13,31). In these cases,
unwanted side reactions occurred in which plasmid inte-
gration rather than cassette exchange occurred, or cassette
exchange occurred in the wrong orientation, making it
necessary to screen for the desired reaction. By using
two different integrases with mutually exclusive att site
recognition, these problems were effectively eliminated.
We found in this study that 111/111 cassette exchange
reactions analyzed had undergone the desired recombin-
ation event (Table 2). In one study (4), a single phiC31
attP site was randomly integrated and successfully used to
target integration of an attB donor plasmid. However,
the use of random integration to place the landing pad
reduced positional control, and the use of a single
integrase site rather than cassette exchange necessitated
the use of a second, FLP-mediated, step to remove
plasmid sequences (4).
The hypothesis that the combined use of two highly site-
speciﬁc integrases would allow more controlled and
speciﬁc cassette exchange appears to have been validated
by this study. It is also notable that no limitation on the
size of the incoming DNA sequence is expected with this
system. We tested different constructs carrying transgene
sizes between the two attB sites ranging from 3 to 7 kb,
and all the sequences were successfully inserted into the
desired locus in our recipient ESC and iPSC lines. In prin-
ciple, it should be possible to insert much larger gene cas-
settes with this system, as has been observed with phiC31
integrase alone (5), and this feature is currently being
tested.
In human and other mammalian cells, phiC31 integrase
is known to be capable of recombining with certain native
sequences called pseudo attP sites that bear partial
identity to its wild-type attP site (32–35). This behavior
is undesirable for DICE, because it could contribute to a
background of undesirable recombination events. To
minimize the possibility of pseudo site integration in our
study, we employed a phiC31 expression vector, pCS-kI
(17), that appears to diminish pseudo site integration
without impacting wild-type attP–attB recombination
(data not shown). This kind of phiC31 activity without
pseudo site interference has also been observed by others
(1–4,31). Work is presently underway in our laboratory to
understand the parameters that are necessary to obtain
these different behaviors from phiC31 integrase, and we
plan to address this subject in a future study.
Genome editing technology is rapidly advancing, and
during our preparation of the H9 ESC recipient cell line
by classical spontaneous HR, the TALEN method for
stimulating recombination efﬁciency was developed
(10,20,21). Although we conﬁrmed that TALEN-assisted
HR occurred at an 8- to 10-fold higher frequency than
spontaneous recombination (Table 1), this new method
also brought some problems that necessitated careful
screening of recombinants. First, it increased the occur-
rence of multiple-copy integration (Figure 3), whereas all
clones derived by spontaneous recombination were single-
copy. Mutations in the vicinity of the double-strand break
were also observed in some TALEN-derived clones. Given
these issues, once a validated, single-copy, mutation-free
recipient cell line is generated by TALEN-assisted recom-
bination, it may be faster and safer to carry out multiple
rounds of gene addition by using highly speciﬁc
integrases, rather than relying upon repeated exposure of
the cells to TALENs, which may produce undesirable
recombinational and mutagenic effects through exposure
of cells to double-strand breaks. In contrast, integrase-
mediated exchange at wild-type att sites is a concerted
strand-exchange reaction that does not produce free
double-strand breaks (18) and has been found to be in-
variably precise to the base (2,6,31,36) (C. Zhao et al.,
submitted for publication).
To compare available methods for genome modiﬁcation
in human pluripotent stem cells, methods relying on
random integration have the serious limitation of lack of
control of the genomic target site, which leads to position
effects on transgene expression and potential perturbation
of endogenous gene expression. Use of HR to control
target site relieves these problems. Endogenous HR is
safe, but relatively inefﬁcient. Recombination stimulated
by TALEN or CRISPR/Cas systems increases recombin-
ation efﬁciency, although off-target effects and introduc-
tion of mutations near the target site are potential
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drawbacks. The DICE system is initially more labori-
ous than use of a TALEN or CRISPR/Cas system
alone, as DICE requires two steps. However, once the
landing pad is inserted, the DICE system allows for
quick and precise genomic editing with a higher efﬁciency
and a clean background. Therefore, particularly when
one desires making multiple lines with different insertions
in the same location, the DICE system is highly
advantageous.
In summary, the combination of HR with DICE
mediated by phiC31 and Bxb1 integrases represents a
practical strategy for rapid and stringent genome editing
in human pluripotent stem cells. After creating a recipient
cell line harboring phiC31 and Bxb1 attP sites, subclones
with conﬁrmed insertion of any gene of interest can easily
be obtained in as short as 2–3 weeks. Positioning trans-
genes at the safe, intergenic, transcriptionally active H11
locus allows diverse genetic manipulations, including
comparison of the functions of different genes in the
same background and during differentiation. While
demonstrated here in human ESC and iPSC at the H11
locus, the DICE system is likely to be successful in a wide
variety of additional cell types, species and genomic
contexts.
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